ArticleAmerican journal of translational research2026
Modified constraint-induced movement therapy improves functional recovery after ischemic stroke and its impacts on exosome-derived microRNAs.
Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate whether modified constraint-induced movement therapy (mCIMT) improves brain function after stroke by increasing the concentrations of exosomes and microRNA.
methodsBlood samples from 16 stroke patients (mCIMT group N=8, control group N=8) were analyzed for cytokines and exosomal microRNAs. Data from electronic medical records and clinical outcomes were also correlated. For the animal model, SD rats underwent middle cerebral artery occlusion (MCAO). The mCIMT group received 2 hours of daily intensive limb training for 14 days, starting 7 days post-MCAO, while the control group was untreated. Exosomes were extracted from brain tissue on day 21, followed by nanoparticle tracking and microRNA sequencing. Exosomes from both groups, as well as a vehicle, were injected into the lateral ventricles of MCAO rats, and they were named the Exo-mCIMT group, Exo-control group and vehicle group. Behavioral tests and histopathological staining were performed on day 21 among the three groups.
resultsmCIMT significantly increased exosome content in the plasma of stroke patients, with exosome size correlated with the Fugl-Meyer Motor Function Assessment (FMA-UE, R
conclusionThese findings suggest that mCIMT promotes neural recovery through increased exosome and microRNA activity in the brain, which plays an important role in neuronal activity after brain injury.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.